My Acute Leukaemia Disappeared within Two Weeks of Practising Falun Dafa

One day in October of 2003, I suddenly developed a very high fever and so I proceeded to the hospital immediately. The doctor could not help. My family took me to Harbin City for better treatment. The Harbin City Blood Research Institute and the Second Hospital of Harbin Medical University diagnosed me with acute Leukaemia (M3 type). My red blood cells were less than one third of the normal count, and my platelets were less than one fifth of the normal quantity.

The doctors informed my family that I "can live for only several days. Even if we find an effective medicine, she cannot survive much longer. Currently there is no way in the world to cure this disease." My family sold almost everything in the house that could be sold and also our land to pay my medical bill. Everyone understands what this situation means for a farmer. In China, many people cannot afford medical care. After being hospitalised for forty days at the Second Hospital of Harbin Medical University, the doctors said, "You peasants have no money. It would not help even if you had any. You must depend on chemotherapy to be kept alive." I left the hospital, because my family had no more money.

After leaving the hospital, I met a Falun Dafa practitioner who introduced the practise to me. Miracles occurred within two weeks after I began practising. I fully recovered, and can again work as healthy person. I can even work in the fields in the cold winter. I am very happy. After the Chinese lunar New Year, I found a new job. I have spent all my free time studying the Falun Gong teachings and doing the exercises. I have become very healthy, and I have not caught a cold or needed any medicine since then.

I benefited from practising Falun Dafa. This is a fact. Falun Dafa has given me a second life. I am writing this article to let people know how good Falun Dafa is.

You are welcome to print and circulate all articles published on Clearharmony and their content, but please quote the source.